Conference abstract · 2 Oct 2017
Conference abstractPublished 20 Jun 2016
Development and characterization of different solid lipid nanocarriers loaded with tamoxifen citrate/ coenzyme Q10 biotherapy for treatment of breast cancer
Helwan University, Egypt; MSA University, Egypt
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Nanotechnology based combinatorial therapy has emerged as an effective strategy for cancer treatment due to anticancer synergistic activity, reduction of drug-related toxicity, suppression of multi-drug resistance and overcoming biomedical barriers against successful delivery of anticancer drugs. Tamoxifen citrate (TC) and coenzyme Q10 (CoQ10) loaded into different types of solid lipid nanocarriers (SLNs) were developed for delivering anticancer/antioxidant drug biotherapy into cancerous cells. Stearic acid (2% w/v) and poloxamer 188 (3%w/v) were selected as optimal lipid matrix and surfactant, respectively for developing biotherapy SLNs. Particle size, polydispersity index (PDI) and zeta potential were 266 nm, 0.741 and -27.5 mv, respectively while, the % encapsulation efficiency (%EE) of TC and CoQ10 were 87% and 38%, respectively. Incorporation of lecithin into lipid matrix has significantly reduced particle size and increased %EE of CoQ10 to 45%. Nanostructured lipid carriers (NLC1) decreased particle size to 81nm and increased %EE to 94% and 56% for TC and CoQ10, respectively. Lipid nanocapsules (LNC2) showed significant effect on decreasing both particle size to 36 nm and %EE to 48% and 30% for TC and CoQ10, respectively. All lipid nanocarriers offered controlled drugs release profiles. Formulations contain phospholipid (SLN11 and NLC1) showed good fitness to Higuchi model with prominent controlling effect for NLC1. Lipid nanocarriers significantly improved TC/CoQ10 permeation through intestinal mucosa with a prominent efficacy to formula SLN11. The study greatly suggests use of TC/CoQ10 solid lipid nanocarriers as potential delivery systems in breast cancer treatment.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 2013
Formulation and Characterization of Tamoxifen Loaded Stealth Liposomes for Breast Cancer
Conference abstract · 10 Aug 2015
Development and characterization of lipid nanocarriers for spironolactone delivery: A comparative study of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC)
Conference abstract · 18 Jul 2018
Formulation and evaluation of Tamoxifen citrate-loaded silk fibroin nanoparticulate drug delivery system
Research article · 31 Dec 2013
Identification and characterization of a novel coenzyme Q10-producing strain, Proteus penneri CA8, newly isolated from Ebolowa, Cameroon
More from this journal
The newest in Journal of Pharmaceutical Care & Health Systems.
Review article · 9 Jun 2025
Blood Fluid: The Unseen Currents That Bind Life and Death Together
Research article · 8 Jun 2025
Formulation and Antibacterial Evaluation of Acmella olaracea (Akarkara) Gummies Used for Toothache
Research article · 9 Apr 2025
Deep Vein Thrombosis: A Closer Look at a Silent Threat
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical Care & Health Systems
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Eman Saddar Inbrahim El-Leithy”
- BylineArticles whose byline prints “Rania S Abdel-Rashid”

